» Articles » PMID: 27876210

Conditioned Medium from LS 174T Goblet Cells Treated with Oxyresveratrol Strengthens Tight Junctions in Caco-2 Cells

Overview
Date 2016 Nov 24
PMID 27876210
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Strengthening of intestinal tight junctions provides an effective barrier from the external environment. Goblet cell-derived trefoil factor 3 (TFF3) increases transepithelial resistance by upregulating the expression of tight junction proteins. Oxyresveratrol (OXY) is a hydroxyl-substituted stilbene found in the roots, leaves, stems, and fruit of many plants and known to have various biological activities. In this study, we investigated the strengthening effect of OXY on intestinal tight junctions through stimulation of TFF production in goblet cells.

Methods: We prepared conditioned medium from LS 174T goblet cells treated with OXY (GCO-CM) and investigated the effect of GCO-CM on strengthening tight junctions of Caco-2 cells. The mRNA and protein expression levels of major tight junction components (claudin-1, occludin, and ZO-1) were measured by quantitative real-time PCR and western blotting, respectively. Transepithelial electric resistance (TEER) was measured using an ohm/V meter. Monolayer permeability was evaluated by paracellular transport of fluorescein isothiocyanate-dextran.

Results: OXY showed a strong antioxidant activity. It significantly increased the expression level of TFF3 in LS 174T goblet cells. GCO-CM prepared by treatment with 2.5, 5, and 10μg/ml OXY did not show cytotoxicity in Caco-2 cells. GCO-CM increased the mRNA and protein expression levels of claudin-1, occludin, and ZO-1. It also significantly increased tight junction integrity and reduced permeability in a dose-dependent manner.

Conclusion: OXY stimulates the expression of TFF3 in goblet cells, which might increase the integrity of the intestinal tight junction barrier.

Citing Articles

Unlocking Gut Health: The Potent Role of Stilbenoids in Intestinal Homeostasis.

Meng T, Wen Z, Cheng X, Li C, Zhang P, Xiao D Animals (Basel). 2025; 15(3).

PMID: 39943187 PMC: 11816141. DOI: 10.3390/ani15030417.


Oxyresveratrol Alleviates Irinotecan-Induced Diarrhea and Enhances Antitumor Effects in Colorectal Cancer.

Yang X, Yu H, Zhou L Drug Des Devel Ther. 2025; 18:6283-6295.

PMID: 39741919 PMC: 11687425. DOI: 10.2147/DDDT.S480179.


Unearthing the Potential Therapeutic Effects of Oxyresveratrol Based on Intrinsic Links between Pharmacological Effects: Implications for the Gut-Liver-Brain Axis.

Zhao L, Duan Y, Li Z, Li J, Li S Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204169 PMC: 11359039. DOI: 10.3390/ph17081063.


Dermal Injection of Recombinant Filaggrin-2 Ameliorates UVB-Induced Epidermal Barrier Dysfunction and Photoaging.

Li L, Liu Y, Chang R, Ye T, Li Z, Huang R Antioxidants (Basel). 2024; 13(8).

PMID: 39199247 PMC: 11351670. DOI: 10.3390/antiox13081002.


Arabinogalactan Alleviates Lipopolysaccharide-Induced Intestinal Epithelial Barrier Damage through Adenosine Monophosphate-Activated Protein Kinase/Silent Information Regulator 1/Nuclear Factor Kappa-B Signaling Pathways in Caco-2 Cells.

Zheng J, Gong S, Han J Int J Mol Sci. 2023; 24(20).

PMID: 37895018 PMC: 10607795. DOI: 10.3390/ijms242015337.